Nevertheless, the result was in line with the phenomenon called “adiponectin paradox” in which adiponectin levels are elevated in some pathological conditions, such as cardiovascular disease, diabetes, and chronic kidney disease [76]. The gene discussed is ADIPOQ; the disease is cardiovascular disorder.